logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
C

Chenxi Qian

University of Toronto
H指数:29
被引数:5,093

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Single-cell multi-omic profiling of heterogeneous PROCR+ cells in mouse mammary gland and its implication for breast cancer

小鼠乳腺中异质性PROCR<sup>+</sup>细胞的单细胞多组学分析及其对乳腺癌的启示

iScience
IF4.1
2026-09-010
OAAI
Koon-Kiu Yan; Erin Nekritz; Zhen Xie; Bensheng Ju; Xinran Dong; Rachel Werner; Dayanira Alsina-Beauchamp; Celeste Rosencrance; Partha Mukhopadhyay; Qingfei Pan; Andrej Gorbatenko; Honglei Zhou; Lei Yan; Liang Ding; Chenxi Qian; Sivaraman Natarajan; Hongbo Chi; John Easton; Jose Silva; Jiyang Yu
Correction: Mirikizumab as Induction and Maintenance Therapy in Chinese Patients with Ulcerative Colitis: A Subpopulation Analysis of the Randomized, Global Phase 3 LUCENT-1 and LUCENT-2 Trials

更正：Mirikizumab作为诱导和维持治疗在中国溃疡性结肠炎患者中的应用：随机全球III期LUCENT-1和LUCENT-2试验的亚组分析

Biodrugs
IF6.9
2026-07-010
OAAI
Zhihua Ran; Yan Chen; Yinglei Miao; Yufang Wang; Xiang Gao; Jie Zhong; Xueli Ding; Chengdang Wang; Xiaolan Zhang; Yijuan Ding; Naizhong Hu; Dan Tang; Jiao Yu; Chenxi Qian; Jun Shen
Mirikizumab as Induction and Maintenance Therapy in Chinese Patients with Ulcerative Colitis: A Subpopulation Analysis of the Randomized, Global Phase 3 LUCENT-1 and LUCENT-2 Trials

美克里zumab在中国溃疡性结肠炎患者中的诱导和维持治疗：随机、全球III期LUCENT-1和LUCENT-2试验的亚群分析

Biodrugs
IF6.9
2026-05-120
OAAI
Zhihua Ran; Yan Chen; Yinglei Miao; Yufang Wang; Xiang Gao; Jie Zhong; Xueli Ding; Chengdang Wang; Xiaolan Zhang; Yijuan Ding; Naizhong Hu; Dan Tang; Jiao Yu; Chenxi Qian; Jun Shen
scMINER: a mutual information-based framework for clustering and hidden driver inference from single-cell transcriptomics data

scMINER：一种基于互信息的框架，用于单细胞转录组数据的聚类和隐藏驱动因子推断

NATURE COMMUNICATIONS
IF15.7
2025-05-080
OA
Pan, Qingfei; Ding, Liang; Hladyshau, Siarhei; Yao, Xiangyu; Zhou, Jiayu; Yan, Lei; Dhungana, Yogesh; Shi, Hao; Qian, Chenxi; Dong, Xinran; Burdyshaw, Chad; Veloso, Joao Pedro; Khatamian, Alireza; Xie, Zhen; Risch, Isabel; Yang, Xu; Yang, Jiyuan; Huang, Xin; Fang, Jason; Jain, Anuj; Jain, Arihant; Rusch, Michael; Brewer, Michael; Peng, Junmin; Yan, Koon-Kiu; Chi, Hongbo; Yu, Jiyang
Abemaciclib combined with endocrine therapy as adjuvant treatment for hormone-receptor-positive, HER2-, high-risk early breast cancer: 5-year Chinese population analysis of the phase III randomized monarchE study

Abemaciclib联合内分泌治疗作为激素受体阳性，HER2-高危早期乳腺癌的辅助治疗: III期随机monarchE研究的5年中国人群分析

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
2024-10-230
OAAI
Zhang, Qingyuan; Shen, Kunwei; Song, Chuan-gui; Ouyang, Quchang; Liu, Zhenzhen; Liu, Qiang; Feng, Jifeng; Chiu, Joanne W. Y.; Tang, Jinhai; Jiang, Zefei; Tseng, Ling-Ming; Wang, Xiaojia; Yang, Liu; Qian, Chenxi; Shao, Zhimin

研究方向

暂未获取到该数据
G
Geoffrey A. Ozin
H 指数:116论文数:976被引数:5.2万
孙
孙威
H 指数:0论文数:0被引数:0
贾佳 封面图
贾佳
H 指数:23论文数:53被引数:3,096
Y
Yuchan Dong
H 指数:18论文数:43被引数:2,906
L
Le He
H 指数:59论文数:333被引数:1.2万
王璐 封面图
王璐
H 指数:67论文数:503被引数:1.7万
G
Geoffrey A. Ozin
H 指数:59论文数:284被引数:1.5万
T
Thomas E. Wood
H 指数:30论文数:90被引数:4,140
L
Laura M. Reyes
H 指数:12论文数:25被引数:1,381
P
Paul G. O’Brien
H 指数:28论文数:103被引数:3,291